128.30000 EUR
3.25
2.47%
Last update Dec 17, 2:06 PM CET
Main market
Day range
128.30000
128.35001
Previous close
131.55000
Open
128.35001
Access this stock data via API
Subscribe
Neurocrine Biosciences Inc.
128.30
3.25
2.47%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 677.6M 586.1M 488.1M 535.1M
Cost of revenue 11.9M 9.6M 7.8M 7.9M
Gross profit 665.7M 576.5M 480.3M 527.2M
Operating expense
Research & development 213.1M 208.3M 224.4M 158.2M
Selling general and admin 248.6M 244.1M 235.7M 245.3M
Other operating expenses
Operating income 204.0M 124.1M 20.2M 123.6M
Non operating interest income
Income
Expense
Other income expense 44.8M 11.8M -7.7M 45.4M
Pretax income 248.8M 136.0M 12.5M 138.6M
Tax provision 70.2M 44.3M 5.8M 50.7M
Net income 178.6M 91.6M 6.7M 87.9M
Basic EPS 1.1 0.1 1.0
Diluted EPS 1.1 0.1 1
Basic average shares 84.4M 85.0M 85.2M
Diluted average shares 86.1M 87.4M 87.7M
EBITDA 165.8M 118.5M 34.4M 109.5M
Net income from continuing op. 178.6M 91.6M 6.7M 87.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 51 minutes

19:08
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).